Risk of infection of health-care workers by human immunodeficiency virus. 1989

A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton

UI MeSH Term Description Entries
D006280 Health Workforce The availability of HEALTH PERSONNEL. It includes the demand and recruitment of both professional and allied health personnel, their present and future supply and distribution, and their assignment and utilization. Health Manpower,Health Occupations Manpower,Manpower, Health,Manpower, Health Occupations,Workforce, Health
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000062 Accidents, Occupational Unforeseen occurrences, especially injuries in the course of work-related activities. Accidents, Industrial,Industrial Accidents,Occupational Accidents,Accident, Industrial,Accident, Occupational,Industrial Accident,Occupational Accident
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
January 2000, AIDS clinical review,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
April 1988, MMWR. Morbidity and mortality weekly report,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
August 1994, Annals of internal medicine,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
July 1989, Archives of internal medicine,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
August 1992, JAMA,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
June 1988, Annals of internal medicine,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
April 1993, The American journal of medicine,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
March 1992, The New Zealand medical journal,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
April 1988, Bulletin of the New York Academy of Medicine,
A Weinmann, and J Chua, and D Spelman, and M McDonald, and W J Spicer, and D Sexton
November 1989, North Carolina medical journal,
Copied contents to your clipboard!